gemifloxacin | CMAC

gemifloxacin

Gemifloxacin in the Treatment of Community-Acquired Lower Respiratory Tract Infections

Gemifloxacin is a new respiratory fluoroquinolone that was approved as Factive® in Russian Federation in December 2005. Among the fluoroquinolones this agent is the most active against Streptococcus pneumoniae, and has similar to other respiratory …